Drug · DIN 02488272
REPLENIX ACNE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 1, 2022.
- Drug Identification Number (DIN)
- 02488272
- Company (DIN owner)
- Topix Pharmaceuticals, Inc.North Amityville, New York, United States
- Schedule
- Non-prescription drugs
- Dosage form
- Solution
- Route
- Topical
- Therapeutic class (ATC)
- Benzoyl peroxide D10AE01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BENZOYL PEROXIDE | 5 % | W/W |